Japan Clinical Oncology Group (JCOG)
Open Access
- 1 March 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 28 (3) , 158-162
- https://doi.org/10.1093/jjco/28.3.158
Abstract
The Japan Clinical Oncology Group (JCOG) is a cooperative oncology group with the aims of conducting, developing, coordinating and stimulating clinical research in Japan on the treatment of cancer and related problems. The purpose of JCOG is to establish and improve the standard of cancer treatment, mainly in solid cancer, through the testing of new therapeutic regimens or combined modalities, using drugs that are newly-approved or already commercially available. Research sponsored by JCOG is accomplished mainly through the execution of large, prospective, randomized, multicenter, clinical trials. In this way, JCOG facilitates the passage of new clinical trial discoveries into state-of-the-art treatment.Keywords
This publication has 27 references indexed in Scilit:
- Interferon Alfa and Zidovudine in Adult T-Cell Leukemia–LymphomaNew England Journal of Medicine, 1995
- A Comparison of Chemotherapy and Radiotherapy as Adjuvant Treatment to Surgery for Esophageal CarcinomaChest, 1993
- Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphomaBritish Journal of Haematology, 1991
- Major prognostic factors of patients with adult T-cell leukemia-lymphoma: A cooperative studyLeukemia Research, 1991
- The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical featuresInternational Journal of Cancer, 1990
- Multi‐step Carcinogenesis Model for Adult T‐cell LeukemiaJapanese Journal of Cancer Research, 1989
- Preoperative Radioactive Therapy for Esophageal CarcinomaChest, 1988
- The third nation‐wide study on adult T‐cell leukemia/lymphoma (ATL) in Japan: Characteristic patterns of hla antigen and HTLV‐I infection in atl patients and their relativesInternational Journal of Cancer, 1988
- Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.Journal of Clinical Oncology, 1988
- Statistical Analyses of Clinico-Pathological, Virological and Epidemiological Data on Lymphoid Malignancies with Special Reference to Adult T-Cell Leukemia/Lymphoma: A Report of the Second Nationwide Study of JapanJapanese Journal of Clinical Oncology, 1985